Related Experiment Video
Updated: May 2, 2026

09:29
Author Spotlight: Hypothalamic Neural Mechanism Insights
Published on: August 4, 2023
4.2K
Potential hypothalamic targets of relaxin-3 innervation: a perspective
Summary
Relaxin-3 neuropeptide signaling influences arousal by interacting with neurons in the lateral hypothalamus and ventrolateral preoptic area. This study maps its distribution to understand its role in arousal control.
Area of Science:
- Neuroscience
- Neuroendocrinology
- Behavioral Neuroscience
Background:
- Relaxin-3 is a neuropeptide primarily expressed in the pontine nucleus incertus.
- It activates the G(i/o)-protein coupled receptor, RXFP3.
- Previous studies suggest relaxin-3 modulates behavioral arousal, but detailed anatomical mapping is limited by antibody availability.
Purpose of the Study:
- To investigate the distribution of relaxin-3 nerve fibers in the mouse lateral hypothalamus (LH) and ventrolateral preoptic area (VLPO).
- To identify potential direct targets of relaxin-3 signaling involved in arousal control.
- To explore the interaction between relaxin-3 and arousal-related neuronal populations.
Main Methods:
- Immunohistochemistry to visualize relaxin-3 immunoreactive nerve fibers.
- Mapping relaxin-3 distribution relative to orexin and parvalbumin in the LH.
- Examining relaxin-3 proximity to galanin-immunoreactive elements in the VLPO.
Main Results:
- Relaxin-3 fibers in the LH were predominantly in the lateral 'PV1' region, with scarce direct contact with parvalbumin neurons.
- In the VLPO, relaxin-3 fibers were found in close proximity to galanin-immunoreactive elements.
- The soma of galanin/GABA neurons projecting to arousal-promoting neurons were not identified.
Conclusions:
- Preliminary findings suggest an interaction between relaxin-3 and VLPO galanin neurons.
- This interaction may contribute to the arousal-promoting effects of relaxin-3.
- Further research is needed to fully elucidate the role of relaxin-3 in arousal regulation.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
5.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
5.7K
Parasympathetic Signaling
4.1K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
4.1K
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.7K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.7K
Hypothalamic-Pituitary Axis
49.2K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
49.2K
Diencephalon: Hypothalamus and Coordination
4.6K
The hypothalamus is a small yet highly complex and essential brain region that plays a crucial role in regulating various bodily functions. Anatomically, it is located at the base of the brain, just above the brainstem and below the thalamus, forming part of the limbic system.
The hypothalamus interacts with other brain regions, including the pituitary gland, through a direct physical connection called the hypothalamic-pituitary axis. The hypothalamus receives somatic and visceral inputs and...
The hypothalamus interacts with other brain regions, including the pituitary gland, through a direct physical connection called the hypothalamic-pituitary axis. The hypothalamus receives somatic and visceral inputs and...
4.6K

